Purification of human erythropoietin by affinity chromatography using cyclic peptide ligands

2018 ◽  
Vol 1085 ◽  
pp. 1-12 ◽  
Author(s):  
William S. Kish ◽  
Matthew K. Roach ◽  
Hiroyuki Sachi ◽  
Amith D. Naik ◽  
Stefano Menegatti ◽  
...  
2017 ◽  
Vol 1500 ◽  
pp. 105-120 ◽  
Author(s):  
William S. Kish ◽  
Hiroyuki Sachi ◽  
Amith D. Naik ◽  
Matthew K. Roach ◽  
Benjamin G. Bobay ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (5) ◽  
pp. 1225
Author(s):  
Jiawen Cao ◽  
Tiantian Fan ◽  
Yanlian Li ◽  
Zhiyan Du ◽  
Lin Chen ◽  
...  

WD40 is a ubiquitous domain presented in at least 361 human proteins and acts as scaffold to form protein complexes. Among them, WDR5 protein is an important mediator in several protein complexes to exert its functions in histone modification and chromatin remodeling. Therefore, it was considered as a promising epigenetic target involving in anti-cancer drug development. In view of the protein–protein interaction nature of WDR5, we initialized a campaign to discover new peptide-mimic inhibitors of WDR5. In current study, we utilized the phage display technique and screened with a disulfide-based cyclic peptide phage library. Five rounds of biopanning were performed and isolated clones were sequenced. By analyzing the sequences, total five peptides were synthesized for binding assay. The four peptides are shown to have the moderate binding affinity. Finally, the detailed binding interactions were revealed by solving a WDR5-peptide cocrystal structure.


Author(s):  
G. R. Barredo ◽  
S. L. Saavedra ◽  
M. C. Martínez-Ceron ◽  
S. L. Giudicessi ◽  
M. M. Marani ◽  
...  

2020 ◽  
Vol 6 (10) ◽  
pp. 1753-1761 ◽  
Author(s):  
Ziyang Zhang ◽  
Rong Gao ◽  
Qi Hu ◽  
Hayden Peacock ◽  
D. Matthew Peacock ◽  
...  

Biochemistry ◽  
2007 ◽  
Vol 46 (44) ◽  
pp. 12709-12720 ◽  
Author(s):  
Sudhir C. Sharma ◽  
Chamila N. Rupasinghe ◽  
Rachel B. Parisien ◽  
Mark R. Spaller

Author(s):  
Alexander Norman ◽  
Charlotte Franck ◽  
Mary Christie ◽  
Paige M. E. Hawkins ◽  
Karishma Patel ◽  
...  

2020 ◽  
Author(s):  
Alexander Norman ◽  
Charlotte Franck ◽  
Mary Christie ◽  
Paige M. E. Hawkins ◽  
Karishma Patel ◽  
...  

ABSTRACTThe COVID-19 pandemic, caused by SARS-CoV-2, has led to substantial morbidity, mortality and disruption globally. Cellular entry of SARS-CoV-2 is mediated by the viral spike protein and affinity ligands to this surface protein have the potential for applications as antivirals and diagnostic reagents. Here, we describe the affinity selection of cyclic peptide ligands to the SARS-CoV-2 spike protein receptor binding domain (RBD) from three distinct libraries (in excess of a trillion molecules each) by mRNA display. We identified six high affinity molecules with dissociation constants (KD) in the nanomolar range (15-550 nM) to the RBD. The highest affinity ligand could be used as an affinity reagent to detect spike protein in solution by ELISA, and the co-crystal structure of this molecule bound to the RBD demonstrated that it binds to a cryptic binding site, displacing a β-strand near the C-terminus. Our findings provide key mechanistic insight into the binding of peptide ligands to the SARS-CoV-2 spike RBD and the ligands discovered in this work may find future use as reagents for diagnostic applications.


Sign in / Sign up

Export Citation Format

Share Document